CIC

Cornercap Investment Counsel Portfolio holdings

AUM $192M
This Quarter Return
+0.77%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$568M
AUM Growth
+$568M
Cap. Flow
-$7.44M
Cap. Flow %
-1.31%
Top 10 Hldgs %
8.56%
Holding
680
New
121
Increased
206
Reduced
110
Closed
119

Sector Composition

1 Financials 19.54%
2 Technology 15.83%
3 Healthcare 14.42%
4 Industrials 12.62%
5 Energy 7.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMRX icon
501
Amneal Pharmaceuticals
AMRX
$2.98B
$208K 0.04%
149,516
SYF icon
502
Synchrony
SYF
$27.7B
$206K 0.04%
7,089
-350
-5% -$10.2K
IMGN
503
DELISTED
Immunogen Inc
IMGN
$205K 0.04%
53,313
+17,246
+48% +$66.2K
FAST icon
504
Fastenal
FAST
$56.5B
$205K 0.04%
+3,794
New +$205K
NUVB icon
505
Nuvation Bio
NUVB
$1.02B
$198K 0.03%
119,285
EQRX
506
DELISTED
EQRx, Inc. Common Stock
EQRX
$196K 0.03%
101,072
-4,526
-4% -$8.78K
ATHA icon
507
Athira Pharma
ATHA
$14.8M
$188K 0.03%
+75,253
New +$188K
NGM
508
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$188K 0.03%
46,062
IPSC icon
509
Century Therapeutics
IPSC
$41.2M
$181K 0.03%
+52,175
New +$181K
OLMA icon
510
Olema Pharmaceuticals
OLMA
$384M
$177K 0.03%
51,152
JNCE
511
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$175K 0.03%
94,783
MRSN icon
512
Mersana Therapeutics
MRSN
$35.9M
$175K 0.03%
42,633
ANNX icon
513
Annexon
ANNX
$232M
$173K 0.03%
45,057
+542
+1% +$2.09K
ITOS icon
514
iTeos Therapeutics
ITOS
$171K 0.03%
+12,557
New +$171K
NRIX icon
515
Nurix Therapeutics
NRIX
$726M
$167K 0.03%
18,756
MGTX icon
516
MeiraGTx Holdings
MGTX
$600M
$166K 0.03%
32,203
+5,256
+20% +$27.2K
STRO icon
517
Sutro Biopharma
STRO
$78.8M
$166K 0.03%
36,009
+248
+0.7% +$1.15K
ERAS icon
518
Erasca
ERAS
$462M
$166K 0.03%
55,066
BCAB icon
519
BioAtla
BCAB
$26.9M
$165K 0.03%
61,534
+28,978
+89% +$77.7K
CGEM icon
520
Cullinan Oncology
CGEM
$454M
$163K 0.03%
15,939
LENZ
521
LENZ Therapeutics
LENZ
$1.1B
$163K 0.03%
66,427
FHTX icon
522
Foghorn Therapeutics
FHTX
$290M
$162K 0.03%
26,163
KLRS
523
Kalaris Therapeutics, Inc. Common Stock
KLRS
$73.5M
$156K 0.03%
39,496
SGMO icon
524
Sangamo Therapeutics
SGMO
$165M
$153K 0.03%
86,934
+19,024
+28% +$33.5K
CCCC icon
525
C4 Therapeutics
CCCC
$183M
$151K 0.03%
48,047
+21,756
+83% +$68.3K